ALOX5 and glioblastoma: Based on the findings of this experimental study, it could be speculated that KuA treatment inhibited the expressions of 5-LOX and C/EBPβ in human GBM cells, which resulted in apoptosis and EMT attenuation of GBM cells, thereby inhibited human GBM cell growth and migration in vitro and in vivo.